Literature DB >> 28017620

Biological variability of the sweat chloride in diagnostic sweat tests: A retrospective analysis.

F Vermeulen1, P Lebecque2, K De Boeck3, T Leal4.   

Abstract

BACKGROUND: The sweat test is the current gold standard for the diagnosis of cystic fibrosis (CF). CF is unlikely when sweat chloride (Clsw) is lower than 30mmol/L, Clsw>60 is suggestive of CF, with intermediate values between 30 and 60mmol/L. To correctly interpret a sweat chloride value, the biological variability of the sweat chloride has to be known.
METHODS: Sweat tests performed in two centers using the classic Gibson and Cooke method were retrospectively reviewed (n=5904). Within test variability of Clsw was measured by comparing results from right and left arm collected on the same day. Between test variability was calculated from subjects with sweat tests performed on more than one occasion.
RESULTS: Within test variability of Clsw calculated in 1022 subjects was low with differences between -3.2 (p5) and +3.6mmol/L (p95). Results from left and right arm were classified differently in only 3 subjects. Between test variability of Clsw in 197 subjects was larger, with differences between -18.2mmol/L (p5) and +14.1mmol/L (p95) between repeat tests. Changes in diagnostic conclusion were seen in 55/197 subjects, the most frequent being changing from indeterminate to 'CF unlikely' range (48/102).
CONCLUSION: Variability of sweat chloride is substantial, with frequent changes in diagnostic conclusion, especially in the intermediate range.
Copyright © 2016 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cystic fibrosis; Diagnosis; Variability

Mesh:

Substances:

Year:  2016        PMID: 28017620     DOI: 10.1016/j.jcf.2016.11.008

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  6 in total

1.  Australasian Guideline (2nd Edition): an Annex to the CLSI and UK Guidelines for the Performance of the Sweat Test for the Diagnosis of Cystic Fibrosis.

Authors:  John Massie; Ronda Greaves; Michael Metz; Veronica Wiley; Peter Graham; Samantha Shepherd; Richard Mackay
Journal:  Clin Biochem Rev       Date:  2017-11

2.  Analytical and biological variation in repeated sweat chloride concentrations in clinical trials for CFTR modulator therapy.

Authors:  V A LeGrys; T C Moon; J Laux; M J Rock; F Accurso
Journal:  J Cyst Fibros       Date:  2017-07-22       Impact factor: 5.482

Review 3.  An Update on CFTR Modulators as New Therapies for Cystic Fibrosis.

Authors:  John A King; Anna-Louise Nichols; Sian Bentley; Siobhan B Carr; Jane C Davies
Journal:  Paediatr Drugs       Date:  2022-05-16       Impact factor: 3.022

4.  Sweat Proteomics in Cystic Fibrosis: Discovering Companion Biomarkers for Precision Medicine and Therapeutic Development.

Authors:  Bastien Burat; Audrey Reynaerts; Dominique Baiwir; Maximilien Fléron; Sophie Gohy; Gauthier Eppe; Teresinha Leal; Gabriel Mazzucchelli
Journal:  Cells       Date:  2022-07-31       Impact factor: 7.666

5.  Soft, skin-interfaced sweat stickers for cystic fibrosis diagnosis and management.

Authors:  Tyler R Ray; Maja Ivanovic; Paul M Curtis; Daniel Franklin; Kerem Guventurk; William J Jeang; Joseph Chafetz; Hannah Gaertner; Grace Young; Steve Rebollo; Jeffrey B Model; Stephen P Lee; John Ciraldo; Jonathan T Reeder; Aurélie Hourlier-Fargette; Amay J Bandodkar; Jungil Choi; Alexander J Aranyosi; Roozbeh Ghaffari; Susanna A McColley; Shannon Haymond; John A Rogers
Journal:  Sci Transl Med       Date:  2021-03-31       Impact factor: 17.956

6.  Passively Addressable Ultra-Low Volume Sweat Chloride Sensor.

Authors:  Antra Ganguly; Shalini Prasad
Journal:  Sensors (Basel)       Date:  2019-10-22       Impact factor: 3.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.